BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talal AH, Ding Y, Venuto CS, Chakan LM, McLeod A, Dharia A, Morse GD, Brown LS, Markatou M, Kharasch ED. Toward precision prescribing for methadone: Determinants of methadone deposition. PLoS One 2020;15:e0231467. [PMID: 32302325 DOI: 10.1371/journal.pone.0231467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Bodnar RJ. Endogenous opiates and behavior: 2020. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170752] [Reference Citation Analysis]
2 Packiasabapathy S, Aruldhas BW, Horn N, Overholser BR, Quinney SK, Renschler JS, Sadhasivam S. Pharmacogenomics of methadone: a narrative review of the literature. Pharmacogenomics 2020;21:871-87. [PMID: 32705966 DOI: 10.2217/pgs-2020-0040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Magarbeh L, Gorbovskaya I, Le Foll B, Jhirad R, Müller DJ. Reviewing pharmacogenetics to advance precision medicine for opioids. Biomed Pharmacother 2021;142:112060. [PMID: 34523422 DOI: 10.1016/j.biopha.2021.112060] [Reference Citation Analysis]
4 Langmia IM, Just KS, Yamoune S, Brockmöller J, Masimirembwa C, Stingl JC. CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations-Implication for Drug Safety, Dosing, and Individualized Therapy. Front Genet 2021;12:692234. [PMID: 34322158 DOI: 10.3389/fgene.2021.692234] [Reference Citation Analysis]
5 Bart G, Giang LM, Yen H, Hodges JS, Brundage RC. Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study. Drug Alcohol Depend 2021;227:109025. [PMID: 34482033 DOI: 10.1016/j.drugalcdep.2021.109025] [Reference Citation Analysis]
6 Sadat Aghabozorg Afjeh S, Boshehri B, Hamednia S, Amini A, Mashayekhi P, Omrani MD. Investigating the CYP2B6 rs3745274 and rs3211371 polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran. Iran Biomed J 2021;25:220-5. [PMID: 33546554 DOI: 10.29252/ibj.25.3.220] [Reference Citation Analysis]
7 Chalabianloo F, Høiseth G, Vold JH, Johansson KA, Kringen MK, Dalgard O, Ohldieck C, Druckrey-Fiskaaen KT, Aas C, Løberg EM, Bramness JG, Fadnes LT. Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. J Addict Dis 2022;:1-11. [PMID: 35356868 DOI: 10.1080/10550887.2022.2057140] [Reference Citation Analysis]